MedPath

Study to compare "levobupivacaine with dexmeditomidine " and "levobupivacaine with dexamethasone " in caudal block for postoperative analgesia

Phase 4
Not yet recruiting
Conditions
Encysted hydrocele, (2) ICD-10 Condition: K409||Unilateral inguinal hernia, without obstruction or gangrene,
Registration Number
CTRI/2023/08/056787
Lead Sponsor
DR Batula Shravani
Brief Summary

This study is a Prospective double blind randomised control study comparing evaluation of 0.25% levobupivacaine with Dexmeditomidine 1ug/kg and 0.25% Levobupivacaine with 1mg/kg dexamethasone in Caudal block in Children undergoing infraumbilical surgeries ,in this study we are comparing postoperative analgesic effect of both the drugs.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients undergoing infraumbilical surgeries Parents or guardian giving consent to participate in study of age between 1year to 8years of ASA Grade I and II.

Exclusion Criteria

Patients guardian not giving consent to participate in the study ASA Grade III and IV Patients with known hypersenstivity to local anaesthestics Abnormal coagulopathy Preexisting neurological disease Local sepsis or infection Mentally retarded child Abnormal sacral anatomy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Its Expected that moderate dose of caudal analgesia with 0.25% levobupivacaine 1ml/kg with dexmeditomidine is more effective than 0.25% levobupivacaine 1ml/kg with dexamethasone24hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Gajraraja medical college and Jah hospital

🇮🇳

Gwalior, MADHYA PRADESH, India

Gajraraja medical college and Jah hospital
🇮🇳Gwalior, MADHYA PRADESH, India
DR Batula Shravani
Principal investigator
7013843124
battulashravani0014@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.